The transcriptional responsiveness of LKB 1 to STAT-mediated signaling is differentially modulated by prolactin in human breast cancer cells

[1]  C. Clevenger,et al.  Role of c-Myb during prolactin-induced signal transducer and activator of transcription 5a signaling in breast cancer cells. , 2009, Endocrinology.

[2]  Gerald C. Chu,et al.  Pancreatic Lkb1 Deletion Leads to Acinar Polarity Defects and Cystic Neoplasms , 2008, Molecular and Cellular Biology.

[3]  W. Farrar,et al.  Nuclear Receptors as Negative Modulators of STAT3 in Multiple Myeloma , 2005, Cell cycle.

[4]  Z. Estrov,et al.  WP1066 disrupts Janus kinase-2 and induces caspase-dependent apoptosis in acute myelogenous leukemia cells. , 2007, Cancer research.

[5]  M. Esteller,et al.  5′-CpG island methylation of theLKB1/STK11 promoter and allelic loss at chromosome 19p13.3 in sporadic colorectal cancer , 2000, Gut.

[6]  Massimo Gadina,et al.  Cytokine Signaling in 2002 New Surprises in the Jak/Stat Pathway , 2002, Cell.

[7]  J. Lebrun,et al.  Defining the role of prolactin as an invasion suppressor hormone in breast cancer cells. , 2006, Cancer research.

[8]  Guohua Zhang,et al.  Wnt signaling may be activated in a subset of Peutz-Jeghers syndrome polyps closely correlating to LKB1 expression. , 2010, Oncology reports.

[9]  K. Yin.  The Mesenchymal-Like Phenotype of the MDA-MB-231 Cell Line , 2011 .

[10]  J. Li,et al.  Wnt modulates MCL1 to control cell survival in triple negative breast cancer , 2014, BMC Cancer.

[11]  H. Sasano,et al.  LKB1 expression is inhibited by estradiol-17β in MCF-7 cells , 2011, The Journal of Steroid Biochemistry and Molecular Biology.

[12]  M. Martins-Green,et al.  A molecular mimic demonstrates that phosphorylated human prolactin is a potent anti-angiogenic hormone. , 2006, Endocrine-related cancer.

[13]  A. Cheema,et al.  STAT3 suppresses transcription of proapoptotic genes in cancer cells with the involvement of its N-terminal domain , 2013, Proceedings of the National Academy of Sciences.

[14]  S. McKnight,et al.  Components of a Stat recognition code: evidence for two layers of molecular selectivity. , 1995, Immunity.

[15]  B. Groner,et al.  Developmental and environmental regulation of a mammary gland-specific nuclear factor essential for transcription of the gene encoding beta-casein. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[16]  B. Groner,et al.  Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. , 1994, The EMBO journal.

[17]  L. Yu-Lee,et al.  Transcriptional Inhibition by Stat5 , 1997, The Journal of Biological Chemistry.

[18]  P. Harvey.  Hypothesis Prolactin is tumorigenic to human breast: dispelling the myth that prolactin‐induced mammary tumors are rodent‐specific , 2012, Journal of applied toxicology : JAT.

[19]  L. Schuler,et al.  PRL activates the cyclin D1 promoter via the Jak2/Stat pathway. , 2002, Molecular endocrinology.

[20]  E. Hugo,et al.  Focus on prolactin as a metabolic hormone , 2006, Trends in Endocrinology & Metabolism.

[21]  E. Hugo,et al.  Adipocyte prolactin: regulation of release and putative functions , 2007, Diabetes, obesity & metabolism.

[22]  W. Ding,et al.  Multiple human prolactin receptors and signaling , 2010 .

[23]  H. Brinkhaus,et al.  JAK2/STAT5 inhibition circumvents resistance to PI3K/mTOR blockade: a rationale for cotargeting these pathways in metastatic breast cancer. , 2012, Cancer cell.

[24]  B. Leiby,et al.  Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo. , 2010, Endocrine-related cancer.

[25]  Esteban Ballestar,et al.  Methyl‐CpG binding proteins identify novel sites of epigenetic inactivation in human cancer , 2003, The EMBO journal.

[26]  H. Gerstein,et al.  Establishing a relationship between prolactin and altered fatty acid β-Oxidation via carnitine palmitoyl transferase 1 in breast cancer cells , 2011, BMC Cancer.

[27]  Tetsuya Yamamoto,et al.  Cross‐talk between signal transducer and activator of transcription 3 and estrogen receptor signaling , 2000, FEBS letters.

[28]  B. Groner,et al.  Beta-casein gene promoter activity is regulated by the hormone-mediated relief of transcriptional repression and a mammary-gland-specific nuclear factor , 1991, Molecular and cellular biology.

[29]  Pavel Kovarik,et al.  Serine phosphorylation of STATs , 2000, Oncogene.

[30]  S. Hankinson,et al.  The role of prolactin in mammary carcinoma. , 2003, Endocrine reviews.

[31]  J. Ihle.  STATs: Signal Transducers and Activators of Transcription , 1996, Cell.

[32]  P Jay,et al.  Specific inhibition of Stat3 signal transduction by PIAS3. , 1997, Science.

[33]  G. Rutter,et al.  RIP2-mediated LKB1 deletion causes axon degeneration in the spinal cord and hind-limb paralysis , 2010, Disease Models & Mechanisms.

[34]  Kristopher C. Carver,et al.  Complex prolactin crosstalk in breast cancer: New therapeutic implications , 2009, Molecular and Cellular Endocrinology.

[35]  R. Hovey,et al.  Prolactin-induced expression of vascular endothelial growth factor via Egr-1 , 2005, Molecular and Cellular Endocrinology.

[36]  James F Amatruda,et al.  Genome-Wide RNAi Screen Reveals Disease-Associated Genes That Are Common to Hedgehog and Wnt Signaling , 2011, Science Signaling.

[37]  Jeremy Green.  Lkb1 and GSK3-beta: kinases at the center and poles of the action. , 2004, Cell Cycle.

[38]  P. Kelly,et al.  Identification of a cDNA encoding a long form of prolactin receptor in human hepatoma and breast cancer cells. , 1989, Molecular endocrinology.

[39]  A. Triplett,et al.  Jak2 is required for the initiation but not maintenance of prolactin-induced mammary cancer , 2010, Oncogene.

[40]  C. Powell,et al.  Printed in U.S.A. Copyright © 1997 by The Endocrine Society Expression of Prolactin and Its Receptor in Human Breast Carcinoma* , 2022 .

[41]  C. Clevenger,et al.  Prolactin as a chemoattractant for human breast carcinoma. , 1999, Endocrinology.

[42]  B. Vonderhaar,et al.  Prolactin Receptor Isoforms in Human Breast Cancer , 2013 .

[43]  K. Liby,et al.  Prolactin as an autocrine/paracrine growth factor in human cancer , 2002, Trends in Endocrinology & Metabolism.

[44]  R. DePinho,et al.  LKB1 (XEEK1) regulates Wnt signalling in vertebrate development , 2003, Nature Cell Biology.

[45]  Warren S. Alexander,et al.  A family of cytokine-inducible inhibitors of signalling , 1997, Nature.

[46]  Chao Ma,et al.  The molecular mechanisms that underlie the tumor suppressor function of LKB1. , 2009, Acta biochimica et biophysica Sinica.

[47]  Z. Shao,et al.  The Tumor Suppressor Gene LKB 1 Is Associated with Prognosis in Human Breast Carcinoma 1 , 2002 .

[48]  L. Ellis,et al.  HIF-1α, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas , 2005, Oncogene.

[49]  Wan-chi Lin,et al.  Targeting janus kinase 2 in Her2/neu-expressing mammary cancer: Implications for cancer prevention and therapy. , 2009, Cancer research.

[50]  Lewis C Cantley,et al.  The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[51]  Soo-Jin Jeong,et al.  Suppression of STAT3 and HIF-1 Alpha Mediates Anti-Angiogenic Activity of Betulinic Acid in Hypoxic PC-3 Prostate Cancer Cells , 2011, PloS one.

[52]  L. Schuler,et al.  Prolactin signals via Stat5 and Oct-1 to the proximal cyclin D1 promoter , 2005, Molecular and Cellular Endocrinology.

[53]  I. Wistuba,et al.  STAT5A-Mediated SOCS2 Expression Regulates Jak2 and STAT3 Activity Following c-Src Inhibition in Head and Neck Squamous Carcinoma , 2011, Clinical Cancer Research.

[54]  D. Neil Hayes,et al.  LKB1 modulates lung cancer differentiation and metastasis , 2007, Nature.

[55]  Taekyu Park,et al.  Methylsulfonylmethane Suppresses Breast Cancer Growth by Down-Regulating STAT3 and STAT5b Pathways , 2012, PloS one.

[56]  J. Frasor,et al.  Prolactin regulation of estrogen receptor expression , 2003, Trends in Endocrinology & Metabolism.

[57]  A. Ishisaki,et al.  Synergistic Effect of Dexamethasone and Prolactin on VEGF Expression in Bovine Mammary Epithelial Cells via p44/p42 MAP Kinase , 2009 .

[58]  Z. Shao,et al.  The tumor suppressor gene LKB1 is associated with prognosis in human breast carcinoma. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[59]  J. Darnell.  STATs and gene regulation. , 1997, Science.

[60]  Gui Yang,et al.  Prolactin mediates psychological stress-induced dysfunction of regulatory T cells to facilitate intestinal inflammation , 2014, Gut.

[61]  A. Richardson,et al.  Reciprocal Effects of STAT5 and STAT3 in Breast Cancer , 2009, Molecular Cancer Research.

[62]  T. Vallenius,et al.  LKB1 in endothelial cells is required for angiogenesis and TGFβ-mediated vascular smooth muscle cell recruitment , 2008, Development.

[63]  P. Kelly,et al.  Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. , 1998, Endocrine reviews.

[64]  J. Herman,et al.  Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome , 2000, Oncogene.

[65]  T. Zhu,et al.  Janus Kinase 2-dependent Activation of p38 Mitogen-activated Protein Kinase by Growth Hormone , 2000, The Journal of Biological Chemistry.

[66]  J. Stephens,et al.  The regulation of fatty acid synthase by STAT5A. , 2005, Diabetes.

[67]  B. Leiby,et al.  Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo. , 2010, Endocrine-related cancer.

[68]  A. Boschero,et al.  Modulation of Gap and Adherens Junctional Proteins in Cultured Neonatal Pancreatic Islets , 2001, Pancreas.

[69]  L. Ivashkiv,et al.  Differential interleukin-6/Stat3 signaling as a function of cellular context mediates Ras-induced transformation , 2010, Breast Cancer Research.

[70]  G. Ronnett,et al.  Leukemia inhibitory factor inhibits neuronal terminal differentiation through STAT3 activation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[71]  S. Shousha,et al.  Expression of prolactin receptors in normal, benign, and malignant breast tissue: an immunohistological study. , 2001, Journal of clinical pathology.

[72]  T. Chiles,et al.  Differential effects of energy stress on AMPK phosphorylation and apoptosis in experimental brain tumor and normal brain , 2008, Molecular Cancer.

[73]  J. Darnell,et al.  A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain. , 1995, Genes & development.

[74]  Ursula A White,et al.  The STAT5A-Mediated Induction of Pyruvate Dehydrogenase Kinase 4 Expression by Prolactin or Growth Hormone in Adipocytes , 2007, Diabetes.

[75]  Amy R. Peck,et al.  PTP1B suppresses prolactin activation of Stat5 in breast cancer cells. , 2010, The American journal of pathology.

[76]  Takaho A. Endo,et al.  A new protein containing an SH2 domain that inhibits JAK kinases , 1997, Nature.

[77]  Alastair M. Thompson,et al.  Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERα negative MDA-MB-435 breast cancer model , 2009, Breast Cancer Research and Treatment.

[78]  I. Parikh,et al.  Estrogenic effect of phenol red in MCF-7 cells is achieved through activation of estrogen receptor by interacting with a site distinct from the steroid binding site. , 1987, Biochemical and biophysical research communications.

[79]  B. Vonderhaar,et al.  Characterization of ductal and lobular breast carcinomas using novel prolactin receptor isoform specific antibodies , 2010, BMC Cancer.

[80]  R. Hovey,et al.  Triennial Lactation Symposium: Prolactin: The multifaceted potentiator of mammary growth and function. , 2012, Journal of animal science.

[81]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[82]  K. Linher-Melville,et al.  Liver kinase B1 expression (LKB1) is repressed by estrogen receptor alpha (ERα) in MCF-7 human breast cancer cells. , 2012, Biochemical and biophysical research communications.

[83]  G. A. Stringer,et al.  Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes , 2012, Breast Cancer Research.

[84]  C. Clevenger,et al.  Prolactin receptor signal transduction in cells of the immune system. , 1998, The Journal of endocrinology.

[85]  Investigaciones Científicas,et al.  Epithelial cell polarity, stem cells and cancer , 2012 .